News

Deal Announcements

Proteus Biomedical Nets $30 Million Series D

Tuesday, October 7, 2008 5:58:00 AM PDT | VentureDeal Staff
Redwood City, California  --  Biotechnology company Proteus Biomedical said that it has secured $30 million in its fourth round of venture capital.

Proteus has created semiconductor biotechnology to assist in the management of congestive heart failure and other cardiovascular diseases.

Investors in the round included Adams Street Partners, Carlyle Growth Partners, Essex Woodlands Health Ventures and Spring Ridge ventures. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1